Present and future of in vitro immunotoxicology in drug development

Journal of Immunotoxicology

Volumn 7, Issue 4, 2010, Pages 255-267

  Galbiati, Valentina ^a   Mitjans, Montserrat ^b   Corsini, Emanuela ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Allergy; Autoimmunity; Cell lines; Human; Immunosuppression; In vitro immunotoxicology

Indexed keywords

XENOBIOTIC AGENT;

AUTOIMMUNITY; CONTACT ALLERGY; EUROPEAN UNION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOSTIMULATION; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; REVIEW; RISK ASSESSMENT; SENSITIZATION;

ANIMALS; BIOLOGICAL PRODUCTS; DRUG EVALUATION, PRECLINICAL; EUROPEAN UNION; GOVERNMENT REGULATION; HAZARDOUS SUBSTANCES; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC TECHNIQUES; IMMUNOMODULATION; MODELS, ANIMAL; TOXICOLOGY;

ANIMALIA;

EID: 78649260280     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.3109/1547691X.2010.509848     Document Type: Review

References (101)

1. 2 and 2, 4-dinitrochlorobenzene. J. Invest. Dermatol 120:390-399.
2. Aiba, S., Manome, H., Yoshino, Y. and Tagami, H. 2000. In vitro treatment of human transforming growth factor-betal-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 101:68-75.
3. Aiba, S., Terunuma, A., Manome, H. and Tagami, H. 1997. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol 27:3031-3038.
4. Arrighi, J. F., Rebsamen, M., Rousset, F., Kindler, V and Hauser, C. 2001. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J. Immunol 166:3837-3845.
5. Arts, J. H., de Jong, W. H., van Triel, J. J., Schijf, M. A., de Klerk, A., van Loveren, H. and Kuper, C. F. 2008. The respiratory local lymph node assay as a tool to study respiratory sensitizers. Toxicol Sci 106:423-434.
6. Ashikaga, T., Hoya, M., Itagaki, H., Katsumura, Y. and Aiba, S. 2002. Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicol In Vitro 16:711-716.
7. Azam, P., Peiffer, J. L., Chamousset, D., Tissier, M. H., Bonnet, P. A., Vian, L., Fabre, I. and Ourlin, J. C. 2006. The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. Toxicol Appl. Pharmacol 212:14-23.
8. Barker, J. N., Mitra, R. S., Griffiths, C. E., Dixit, V. M. and Nickoloff, B. J. 1991. Keratinocytes as initiators of inflammation. Lancet 337:211-214.
9. Basketter, D. A. 2007. An evaluation of selected global (Q) SARs/expert systems for the prediction of skin sensitisation potential. SAR QSAR Environ Res. 18:515-541.
10. Basketter, D., Pease, C., Kasting, G., Kimber, I., Casati, S., Cronin, M., Diembeck, W., Gerberick, F., Hadgraft, L., Hartung, T., Marty, J. P., Nikolaidis, E., Patlewicz, G., Roberts, D., Roggen, E., Rovida, C. and van de Sandt, J. 2007. Skin sensitisation and epidermal disposition: The relevance of epidermal disposition for sensitisation hazard identification and risk assessment. The report and recommendations of ECVAM workshop 59. Altern. Lab. Anim. 35:137-154.
11. Basketter, D. and Maxwell, G. 2007. In vitro approaches to the identification and characterization of skin sensitizers. Cutan. Ocul. Toxicol. 26:359-373. (Pubitemid 350208874)
12. + T-lymphocytes: New partners in TCR/CD28 signal integration. Mot Immunol 38:1087-1099.
13. Bini, E. J. and Weinshel, E. H. 1999. Severe exacerbation of asthma: A new side effect of interferon-alpha in patients with asthma and chronic hepatitis C. Mayo Clin. Proc. 74:367-370.
14. Boverhof, D. R., Billington, R., Gollapudi, B. B., Hotchkiss, J. A., Krieger, S. M., Poole, A., Wiescinski, C. M. and Woolhiser, M. R. 2008. Respiratory sensitization and allergy: Current research approaches and needs. Toxicol Appl Pharmacol. 226:1-13.
15. 1 mice: II. Metanitrotoluene. Drug Chem. Toxicol. 17:359-399.
16. Byers, A. M., Tapia, T. M., Sassano, E. R. and Wittman, V. 2009. In vitro antibody response to tetanus in the MIMIC system is a representative measure of vaccine immunogenicity. Biologicals 37:148-151.
17. Carfi, M., Gennari, A., Malerba, I., Corsini, E., Pallardy, M., Pieters, R., Van Loveren, H., Vohr, H. W., Hartung, T. and Gribaldo, L. 2007. In vitro tests to evaluate immunotoxicity: A preliminary study. Toxicology 229:11-22.
18. Casati, S., Aeby, P., Basketter, D. A., Cavani, A., Gennari, A., Gerberick, G. F., Griem, P., Hartung, T., Kimber, I., Lepoittevin, J. P., Meade, B. J., Pallardy, M., Rougier, N., Rousset, F., Rubinstenn, G., Sallusto, F., Verheyen, G. R. and Zuang, V.; Report and Recommendations of ECVAM Workshop 51. 2005. Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. Altern Lab. Anim. 33:47-62.
19. Caux, C., Dezutter-Dambuyant, C., Schmitt, D. and Banchereau, J. 1992. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258-261.
20. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I. and Banchereau, J. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263-1272.
21. Cella, M., Salio, M., Sakakibara, Y., Langen, H., lulkunen, I. and Lanzavecchia, A. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821-829.
22. Condevaux, F., Guichard, J., Forichon, A., Aujoulat, M. and Descotes, J. 2001. Compared effects of morphine and nickel chloride on NK cell activity in vitro in rats and monkeys. J. Appl. Toxicol. 21:431-434.
23. Corsini, E., Limiroli, E., Marinovich, M., Cohen, C., Roguet, R. and Galli, C. L. 1999. Selective induction of IL-12 by chemical allergens in reconstituted human epidermis. Altern. Lab. Anim. 27:261-269.
24. Corsini, E., Mitjans, M., Galbiati, V., Lucchi, L., Galli, C. L. and Marinovich, M. 2009. Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol. In Vitro 23:789-796.
25. Corsini, E., Primavera, A., Marinovich, M. and Galli, C. L. 1998. Selective induction of cell-associated interleukin-lalpha in murine keratinocytes by chemical allergens. Toxicology 129:193-200.
26. Corsini, E. and House, R. V. 2010. Evaluating cytokines in immunotoxicity testing. Methods Mol Biol. 598:283-302.
27. Coutant, K. D., de Fraissinette, A. B., Cordier, A., Ulrich, P. 1999. Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol Sci. 52:189-98.
28. Dai, R. and Streilein, J. W. 1998. Naive, hapten-specific human T-lymphocytes are primed in vitro with derivatized blood mononuclear cells. J. Invest. Dermatol. 110:29-33.
29. de long, W. H., Arts, J. H., De Klerk, A., Schijf, M. A., Ezendam, J., Kuper, C. F. and Van Loveren, H. 2009. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure. Toxicology 261:103-111.
30. +-derived DC by NiCl (2) and SDS. Toxicol In Vitro 15:319-325.
31. Dearman, R. J., Warbrick, E. V., Skinner, R. and Kimber, I. 2002. Cytokine fingerprinting of chemical allergens: Species comparisons and statistical analyses. Food Chem. Toxicol. 40:1881-1892.
32. Degwert, J. S., Hoppe, U., and Kligman, L. H. 1997. In vitro model for contact sensitization: I. Stimulatory capacities of human blood-derived dendritic cells and their phenotypical alterations in the presence of contact sensitizers. Toxicol. In Vitro 11:613-618.
33. Demoly, P. and Bousquet, J. 2001. Epidemiology of drug allergy. Curr. Opin. Allergy Clin Immunol. 1:305-310.
34. ECETOC (European Center for Ecotoxicology and Toxicology of Chemicals). 2005. Workshop on Chemical Pollution, Respiratory Allergy, and Asthma. Workshop report No. 6.
35. Emter, R., Ellis, G. and Natsch, A. 2010. Performance of a novel keratinocytebased reporter cell line to screen skin sensitizers in vitro. Toxicol Appl. Pharmacol. 245:281-290.
36. Enk, A. H. and Katz, S. I. 1992. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. U. S. A. 89:1398-1402.
37. Esser, C. and lux, B. 2009. Small chemicals, bioactivation, and the immune system-a fragile balance of i-tox and benefits? Chem. Biodivers. 6:2138-2143.
38. Fauci, A. S. and Pratt, K. R. 1976. Activation of human B-lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes. J. Exp. Med. 144:674-684.
39. Flavell, R. A., Dong, C. and Davis, R. J. 2002. Signaling and cell death in lymphocytes. Inflamm. Res. 51:80-82.
40. Fleming, D. M., Sunderland, R., Cross, K. W. and Ross, A. M. 2000. Declining incidence of episodes of asthma: A study of trends in new episodes presenting to general practitioners in the period 1989-98. Thorax 55:657-661.
41. Gennari, A., Ban, M., Braun, A., Casati, S., Corsini, E., Dastych, J., Descotes, J., Hartung, T., Hooghe-Peters, R., House, R., Pallardy, M., Pieters, R., Reid, L., Tryphonas, H., Tschirhart, E., Tuschl, H., Vandebriel, R. and Gribaldo, L. 2005. The Use of In Vitro Systems for Evaluating Immunotoxicity: The Report and Recommendations of an ECVAM Workshop. J. Immunotoxicol. 2:61-83.
42. Gerberick, F., Aleksic, M., Basketter, D., Casati, S., Karlberg, A. T., Kern, P., Kimber, I., Lepoittevin, J. P., Natsch, A., Ovigne, J. M., Rovida, C., Sakaguchi, H. and Schultz, T. 2008. Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. Altern. Lab. Anim. 36:215-242.
43. Gerberick, G. F., Ryan, C. A., Dearman, R. J. and Kimber, I. 2007a. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals. Methods 41:54-60.
44. Gerberick, G. F., Vassallo, J. D., Foertsch, L. M., Price, B. B., Chaney, J. G. and Lepoittevin, J. P. 2007b. Quantification of chemical peptide reactivity for screening contact allergens: A classification tree model approach. Toxicol. Sci. 97:417-427.
45. Germolec, D. E. 2004. Sensitivity and predictivity in immunotoxicity testing: Immune endpoints and disease resistance. Toxicol. Lett. 149:109-114.
46. Gorbachev, A. V. and Fairchild, R. L. 2001. Induction and regulation of T-cell priming for contact hypersensitivity. Crit. Rev. Immunol. 21:451-472.
47. Grabbe, S. and Schwarz, T. 1996. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Am. J. Contact Dermatitis 7:238-246.
48. Grabbe, S., Steinert, M., Mahnke, K., Schwartz, A., Luger, T. A. and Schwarz, T. 1996. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but non-specific pro-inflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis. J. Clin. Invest. 98:1158-1164.
49. Hacker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B. and Wagner, H. 1998. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17:6230-6240.
50. Hebert, P. and Pruett, S. B. 2001. Selective loss of viability of mouse NK cells in culture is associated with decreased NK cell lytic function. In Vitro Mol. Toxicol. 14:71-82.
51. Henjakovic, M., Martin, C., Hoymann, H. G., Sewald, K., Ressmeyer, A. R., Dassow, C., Pohlmann, G., Krug, N., Uhlig, S. and Braun, A. 2008. Ex vivo lung function measurements in precision-cut lung slices (PCLS) from chemical allergen-sensitized mice represent a suitable alternative to in vivo studies. Toxicol. Sci. 106:444-453.
52. Hermann, C., von Aulock, S., Graf, K. and Hartung, T. 2003. A model of human whole blood lymphokine release for in vitro and ex vivo use. J. Immunol. Methods. 275:69-79.
53. House, R. V 2000. An overview of in vitro/ex vivo assays for preclinical evaluation of immunomodulation. Hum. Exp. Toxicol. 19:246-250.
54. House, R. V. 2001. Cytokine measurement techniques for assessing hypersensitivity. Toxicology 158:51-58.
55. Howes, D., Guy, R., Hadgraft, J., Heylings, J. R., Hoeck, U., Kemper, F., Maibach, H., Marty, J.-P., Merk, H., Parra, J., Rekkas, D., Rondelli, I., Shaeffer, H., Tauber, U. and Verbiese, N. 1996. Methods for Assessing Percutaneous Absorption. ECVAM Workshop Report 13. Altern. Lab. Anim. 24:81-106.
56. Katz, S. I., Tamaki, K. and Sachs, D. H. 1979. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282:324-326.
57. Kimber, I. and Dearman, R. J. 2005. What makes a chemical a respiratory sensitizer? Curr. Opin. Allergy Clin. Immunol. 5:119-124.
58. Kimber, I. and Weisenberger, C. 1989. A murine local lymph node assay for the identification of contact allergens. Assay development and results of an initial validation study. Arch. Toxicol. 63:274-282. (Pubitemid 19181044)
59. Klein, N. C., Go, C. H. and Cunha, B. A. 2001. Infections associated with steroid use. Infect. Dis. Clin. North Am. 15:423-32, viii.
60. Koeper, L. M. and Vohr, H. W. 2009. Functional assays are mandatory for a correct prediction of immunotoxic properties of compounds in vitro. Food Chem. Toxicol. 47:110-118.
61. Langenkamp, A., Casorati, G., Garavaglia, C., Dellabona, P., Lanzavecchia, A. and Sallusto, F. 2002. T cell priming by dendritic cells: Thresholds for proliferation, differentiation and death and intraclonal functional diversification. Eur. J. Immunol. 32:2046-2054.
62. Langezaal, I., Coecke, S. and Hartung, T. 2001. Whole blood cytokine response as a measure of immunotoxicity. Toxicol. In Vitro 15:313-318.
63. Langezaal, I., Hoffmann, S., Hartung, T. and Coecke, S. 2002. Evaluation and prevalidation of an immunotoxicity test based on human whole-blood cytokine release. Altern. Lab. Anim. 30:581-595.
64. Lebrec, H., Roger, R., Blot, C., Burleson, G. R., Bohuon, C. and Pallardy, M. 1995. Immunotoxicological investigation using pharmaceutical drugs. In vitro evaluation of immune effects using rodent or human immune cells. Toxicology 96:147-156.
65. Li, Q. 2010. NK cell assays in immunotoxicity testing. Methods Mol. Biol. 598:207-219.
66. Luster, M. I., Portier, C., Pait, D. G., White, K. L. Jr., Gennings, C., Munson, A. E. and Rosenthal, G. J. 1992. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:200-210.
67. Luster, M. I. and Rosenthal, G. J. 1993. Chemical agents and the immune response. Environ. Health Perspect. 100:219-226.
68. Maino, V. C. and Picker, L. J. 1998. Identification of functional subsets by flow cytometry: Intracellular detection of cytokine expression. Cytometry 34:207-215.
69. Marcusson-Ståhl, M. and Cederbrant, K. 2003. A flow-cytometric NK cytotoxicity assay adapted for use in rat repeated dose toxicity studies. Toxicology 193:269-279.
70. Miossec, P. 1997. Cytokine-induced autoimmune disorders. Drug Saf. 17:93-104.
71. Mishell, R. I. and Dutton, R. W. 1967. Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126:423-442.
72. Mitjans, M., Viviani, B., Lucchi, L., Galli, C. L., Marinovich, M. and Corsini, E. 2008. Role of p38 MAPK in the selective release of IL-8 induced by chemical allergen in naive THP-1 cells. Toxicol In Vitro. 22:386-395.
73. + T-cells. J. Immunol Methods 353:8-19.
74. Miiller, G., Saloga, I., Germann, T., Bellinghausen, I., Mohamadzadeh, M., Knop, I. and Enk, A. H. 1994. Identification and induction of human keratinocyte-derived IL-12. J. Clin. Invest. 94:1799-1805.
75. Netzeva, T. I., Worth, A., Aldenberg, T., Benigni, R., Cronin, M. T., Gramatica, P., laworska, I. S., Kahn, S., Klopman, G., Marchant, C. A., Myatt, G., Nikolovaleliazkova, N., Patlewicz, G. Y., Perkins, R., Roberts, D., Schultz, T., Stanton, D. W., van de Sandt, J. J., Tong, W., Veith, G. and Yang, C. 2005. Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52. Altern. Lab. Anim. 33:155-173.
76. Nukada, Y., Miyazawa, M., Kosaka, N., Ito, Y., Sakaguchi, H. and Nishiyama, N. 2008. Production of IL-8 in THP-1 cells following contact allergen stimulation via mitogen-activated protein kinase activation or tumor necrosis factor-alpha production. J. Toxicol Sci. 33:175-185.
77. Pasqualetti, D., Ghirardini, A., Cafolla, A., Biffoni, M., Coluzzi, S., Vaglio, S. and Girelli, G. 2003. Lymphocyte T subsets and natural killer cells in Italian and Philippino blood donors. Vox Sang. 84:68-72.
78. Patlewicz, G., Aptula, A. O., Uriarte, E., Roberts, D. W., Kern, P. S., Gerberick, G. F., Kimber, I., Dearman, R. I., Ryan, C. A. and Basketter, D. A. 2007. An evaluation of selected global (Q) SARs/expert systems for the prediction of skin sensitisation potential. SAR QSAR Environ. Res. 18:515-541.
79. Pessina, A., Albella, B., Bueren, I., Brantom, P., Casati, S., Gribaldo, L., Croera, C., Gagliardi, G., Foti, P., Parchment, R., Parent-Massin, D., Sibiril, Y. and Van Den Heuvel, R. 2001. Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicol. In Vitro 15:729-740.
80. Pieters, R. 2007. Detection of autoimmunity by pharmaceuticals. Methods 41:112-117.
81. Pieters, R., Ezendam, I., Bleumink, R., Bol, M. and Nierkens, S. 2002. Predictive testing for autoimmunity. Toxicol. Lett. 127:83-91.
82. Ringerike, T., Ullerås, E., Völker, R., Verlaan, B., Eikeset, A., Trzaska, D., Adamczewska, V., Olszewski, M., Walczak-Drzewiecka, A., Arkusz, I., van Loveren, H., Nilsson, G., Lovik, M., Dastych, I. and Vandebriel, R. I. 2005. Detection of immunotoxicity using T-cell based cytokine reporter cell lines ("Cell Chip"). Toxicology 206:257-272.
83. Ross, P., De Swart, R., Addison, R., Van Loveren, H., Vos, I. and Osterhaus, A. 1996. Contaminant-induced immunotoxicity in harbour seals: Wildlife at risk? Toxicology 112:157-169.
84. Rougier, N., Redziniak, G., Mougin, D., Schmitt, D. and Vincent, C. 2000. In vitro evaluation of the sensitization potential of weak contact allergens using langerhans-like dendritic cells and autologous T-cells. Toxicology 145:73-82.
85. Rustemeyer, T., De Ligter, S., Von Blomberg, B. M., Frosch, P. I. and Scheper, R. I. 1999. Human T-lymphocyte priming in vitro by haptenated autologous dendritic cells. Clin Exp. Immunol. 117:209-216.
86. Sakaguchi, H., Ashikaga, T., Miyazawa, M., Kosaka, N., Ito, Y., Yoneyama, K., Sono, S., Itagaki, H., Toyoda, H. and Suzuki, H. 2009. The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test-human cell line activation test (h-CLAT). Cell Biol. Toxicol. 25:109-126.
87. Seed, M. I., Cullinan, P. and Agius, R. M. 2008. Methods for the prediction of low-molecular-weight occupational respiratory sensitizers. Curr. Opin. Allergy Clin Immunol. 8:103-109.
88. Sia, I. G. and Paya, C. V 1998. Infectious complications following renal transplantation. Surg. Clin. North Am. 78:95-112.
89. Sly, R. M. 1999. Changing prevalence of allergic rhinitis and asthma. Ann. Allergy Asthma Immunol. 82:233-248.
90. Sleijffers, A., Garssen, I. and Van Loveren, H. 2002. Ultraviolet radiation, resistance to infectious diseases, and vaccination responses. Methods. 28:111-121.
91. Thurm, C. W. and Halsey, I. F. 2005. Measurement of cytokine production using whole blood. Curr. Protoc. Immunol. Chapter 7: Unit 7.18B.
92. Thyssen, I. P. and Menné, T. 2010. Metal allergy-a review on exposures, penetration, genetics, prevalence, and clinical implications. Chem. Res. Toxicol. 23:309-318.
93. Tuschl, H., Kovac, R. and Weber, E. 2000. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol. In Vitro 14:541-549.
94. van de Sandt, I. I., Roguet, R., Cohen, C., Esdaille, D., Ponec, M., Corsini E., Barker, B., Fusenig, N., Liebsch, M., Benford, D., de Brugerolle de Fraissinette, A., and Fortasch, M. 2002. The use of human keratinocytes and human skin models for predicting skin irritation. The report and recommendations of ECVAM workshop. Altern Lab. Anim. 27:723-743.
95. van Och, F. M., Van Loveren, H., Van Wolfswinkel, I. C., Machielsen, A. I. and Vandebriel, R. I. 2005. Assessment of potency of allergenic activity of low molecular weight compounds based on IL-lalpha and IL-18 production by a murine and human keratinocyte cell line. Toxicology 210:95-109.
96. van Schayck, C. P. and Smit, H. A. 2005. The prevalence of asthma in children: A reversing trend. Eur. Respir. J. 26:647-650.
97. Verstraelen, S., Nelissen, I., Hooyberghs, I., Witters, H., Schoeters, G., Van Cauwenberge, P. and Van Den Heuvel, R. 2009. Gene profiles of THP-1 macrophages after in vitro exposure to respiratory (non-) sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicol. In Vitro. 23:1151-1162.
98. Vial, T. and Descotes, J. 2003. Immunosuppressive drugs and cancer. Toxicology 185:229-240.
99. H2 skew in an in vitro allergy model. J. Immunol 172:6080-6086.
100. Wohlsen, A., Martin, C., Vollmer, E., Branscheid, D., Magnussen, H., Becker, W. M., Lepp, U. and Uhlig, S. 2003. The early allergic response in small airways of human precision-cut lung slices. Eur. Respir. J. 21:1024-1032.
101. Yoshida, Y., Sakaguchi, H., Ito, Y., Okuda, M. and Suzuki, H. 2003. Evaluation of the skin sensitization potential of chemicals using expression of costimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. Toxicol In Vitro. 17:221-228.